Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.29%
#2 Ocean Protocol Ocean Protocol +16.95%
#3 KUB Coin KUB Coin +12.98%
#4 Cysic Cysic +11.71%
#5 Perle Perle +11.29%
#6 Audiera Audiera +10.79%
#7 Arowana Arowana +10.33%
#8 Geodnet Geodnet +9.94%
#9 Wiki Cat Wiki Cat +9.69%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Clasificación en acciones #32247
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Precio por acción
$0.8013
Última sincronización: 2026-08-05
Capitalización bursátil
$10.62M
Cambio (1 día)
0.97%
Cambio (1 año)
-37.88%
País
US
Comercio Hoth Therapeutics, Inc. (HOTH)

Categoría

Healthcare
Ratio P/S de Hoth Therapeutics, Inc. (HOTH)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Hoth Therapeutics, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Hoth Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR